[go: up one dir, main page]

AU7592998A - Modulators of tissue regeneration - Google Patents

Modulators of tissue regeneration

Info

Publication number
AU7592998A
AU7592998A AU75929/98A AU7592998A AU7592998A AU 7592998 A AU7592998 A AU 7592998A AU 75929/98 A AU75929/98 A AU 75929/98A AU 7592998 A AU7592998 A AU 7592998A AU 7592998 A AU7592998 A AU 7592998A
Authority
AU
Australia
Prior art keywords
modulators
tissue regeneration
regeneration
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75929/98A
Inventor
Richard L. Cate
Catherine A. Hession
Michele Sanicola-Nadel
Henry Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of AU7592998A publication Critical patent/AU7592998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU75929/98A 1997-05-23 1998-05-22 Modulators of tissue regeneration Abandoned AU7592998A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4749197P 1997-05-23 1997-05-23
US4749097P 1997-05-23 1997-05-23
US60047490 1997-05-23
US60047491 1997-05-23
PCT/US1998/010547 WO1998053071A1 (en) 1997-05-23 1998-05-22 Modulators of tissue regeneration

Publications (1)

Publication Number Publication Date
AU7592998A true AU7592998A (en) 1998-12-11

Family

ID=26725083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75929/98A Abandoned AU7592998A (en) 1997-05-23 1998-05-22 Modulators of tissue regeneration

Country Status (5)

Country Link
EP (1) EP0983357A1 (en)
JP (1) JP2002516572A (en)
AU (1) AU7592998A (en)
CA (1) CA2290783A1 (en)
WO (1) WO1998053071A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757698B2 (en) * 1998-06-01 2003-03-06 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040141975A1 (en) 1998-06-01 2004-07-22 Raitano Arthur B. Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20060052321A1 (en) 2002-04-05 2006-03-09 Raitano Arthur B Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US6451969B1 (en) 1999-01-15 2002-09-17 The Burnham Institute Methods for inhibiting tumor metastasis, and peptides useful therfor
EP1176200A3 (en) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
AU2001271902A1 (en) * 2000-07-06 2002-01-21 Deltagen, Inc. Transgenic mice containing targeted gpcr gene disruptions
US6717032B2 (en) 2000-07-06 2004-04-06 Deltagen, Inc Transgenic mice containing DEZ orphan receptor gene disruptions
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
EP1436390A4 (en) * 2001-02-22 2005-07-20 Univ Rochester RETINOID-INDUCIBLE PROTEINS OF VASCULAR SMOOTH MUSCLE CELLS AND USES THEREOF
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
AUPR470101A0 (en) 2001-05-02 2001-05-24 Murdoch Childrens Research Institute, The A molecular marker
JP2005505271A (en) 2001-09-06 2005-02-24 アジェンシス, インコーポレイテッド Nucleic acids and corresponding proteins given the name STEAP-1 useful in the treatment and detection of cancer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
JP2007525434A (en) 2003-03-19 2007-09-06 アブジェニックス インコーポレイテッド Antibodies to T cells, immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof.
SI1742966T1 (en) 2004-04-22 2014-03-31 Agensys, Inc. Antibodies and molecules derived therefrom that bind to steap-1 proteins
JP2009515897A (en) 2005-11-10 2009-04-16 キュラジェン コーポレイション Methods of treating ovarian and renal cancer using antibodies to immunoglobulin domains of murine domain and mucin domain 1 (TIM-1) antigen
ES2636089T3 (en) 2006-10-27 2017-10-05 Genentech, Inc. Antibodies and immunoconjugates and uses for them
WO2009025117A1 (en) 2007-08-20 2009-02-26 Oncotherapy Science, Inc. Cdca1 peptide and pharmaceutical agent comprising the same
TWI526219B (en) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Cdca1 epitope peptides and vaccines containing the same
WO2014010229A1 (en) * 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Cdca1 epitope peptides for th1 cells and vaccines containing the same
AU2018247767B2 (en) 2017-04-03 2025-01-30 F. Hoffmann-La Roche Ag Antibodies binding to STEAP-1
CN119552214B (en) * 2025-01-26 2025-04-22 杭州康源食品科技有限公司 Tetrapeptide LILP with uric acid reducing activity and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026732A1 (en) * 1994-03-31 1995-10-12 Amur Research Corp. Diagnostic marker and method for determining renal function in mammals
US5552313A (en) * 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
PL188826B1 (en) * 1996-05-24 2005-04-29 Biogen Tissue regeneration modulators

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757698B2 (en) * 1998-06-01 2003-03-06 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
AU757698C (en) * 1998-06-01 2004-04-08 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof

Also Published As

Publication number Publication date
WO1998053071A1 (en) 1998-11-26
CA2290783A1 (en) 1998-11-26
JP2002516572A (en) 2002-06-04
EP0983357A1 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
HUP9902770A3 (en) Modulators of tissue regeneration
AU7592998A (en) Modulators of tissue regeneration
AU2557397A (en) Removal of tissue
EP0788804A3 (en) Medical applicator
AU2218395A (en) Bone regeneration
AU6790998A (en) Suture-passing forceps
AU1408199A (en) Patient support surfaces
AU6506698A (en) Tissue implant
AU6042298A (en) Tissue factor pathway inhibitor-3
AU1036697A (en) Surgical anchorage
AU6034096A (en) Disposable applicator
AU2315797A (en) Promotion of regeneration of organized tissues
AU6928098A (en) Optical modulator
AU2749395A (en) Medical use of bromelain
AU5055996A (en) Switched-inverter modulator
AU3145795A (en) Fibrin-cell suspension for construction of new tissue
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6893996A (en) Use of catalysts
AU8408498A (en) Surgical handpiece
AU2870597A (en) Treatment of liquid
AU1112099A (en) Tissue removal
AU6883398A (en) Methods of treating bone loss
AU1570199A (en) Methods of lyophilizing solutions
AU2500797A (en) Methods of modulating t-cell activation
AU4931697A (en) Operation of optical modulators

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase